Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity
(Q43275812)
scientific article published on 25 August 2009
scientific article published on 25 August 2009
Language:
Current Data About
Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity